Drug Type Peptide drug conjugates |
Synonyms AT-301(A28 Therapeutics) |
Target |
Action modulators |
Mechanism FSHR modulators(Follicle-stimulating hormone receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | United States | 02 Aug 2024 |





